Solius: Funding, Investors & Team (Sep 2026)
Solius is a new technology to help vitamin D deficient Canadian for human health. The company is designed to harness the healing powers of the sun to stimulate the production of vitamin D without the harmful UVA rays or issues related to supplements. They provide the benefits of the sun without the harmful rays to unlock the healing powers of the human body, improving physical, mental, and immune function. Solius stimulates the body’s production of hormones and peptides critical to many aspects of health and wellbeing. Every element of SOLIUS has been designed to enhance the user experience and set a new standard for medical devices everywhere. Solius also developed an ultraviolet light system to help treat COVID-19. Solius was founded in 2011 and is headquartered in Bainbridge Island, Washington, United States.
Solius has raised $3.5M across 1 funding round on record, the most recent an undisclosed round of $3.5M announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solius Company Profile and Key Stats
Latest funding round on record: May 2026.
Solius Funding Rounds
Solius Founders and Leadership Team
Contact details for the Solius team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Solius Funding Compared to Other Biotechnology Startups
Solius' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solius in Biotechnology and Bainbridge Island
Companies Similar to Solius
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Solius Funding FAQs
What does Solius do?
Solius is a new technology to help vitamin D deficient Canadian for human health. The company is designed to harness the healing powers of the sun to stimulate the production of vitamin D without the harmful UVA rays or issues related to supplements. They provide the benefits of the sun without the harmful rays to unlock the healing powers of the human body, improving physical, mental, and immune function. Solius stimulates the body’s production of hormones and peptides critical to many aspects of health and wellbeing. Every element of SOLIUS has been designed to enhance the user experience and set a new standard for medical devices everywhere. Solius also developed an ultraviolet light system to help treat COVID-19. Solius was founded in 2011 and is headquartered in Bainbridge Island, Washington, United States.
How much funding has Solius raised?
Solius has raised $3.5M across 1 round on record. The most recent is an undisclosed round of $3.5M announced in May 2026.
When did Solius last raise funding?
Solius' most recent funding round on record is an undisclosed round of $3.5M, announced in May 2026.
Who founded Solius?
FundedIQ lists Christopher Kiple (Founder) at Solius.
Where is Solius headquartered?
Solius is based in Bainbridge Island, Washington, United States.
How many employees does Solius have?
Solius is in the 11-50 employee band.
How does Solius' funding compare to other Biotechnology startups?
Solius' latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Solius Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solius is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.